Robert Duncan, P.A

NPI: 1669492609
Total Payments
$3,429
2024 Payments
$1,572
Companies
36
Transactions
186
Medicare Patients
295
Medicare Billing
$42,878

Payment Breakdown by Category

Food & Beverage$3,429 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,429 186 100.0%

Top Paying Companies

Company Total Records Latest Year
Daiichi Sankyo Inc. $559.49 33 $0 (2024)
Novartis Pharmaceuticals Corporation $489.73 25 $0 (2024)
Janssen Biotech, Inc. $263.78 15 $0 (2024)
Merck Sharp & Dohme LLC $208.87 12 $0 (2024)
AstraZeneca Pharmaceuticals LP $173.03 10 $0 (2024)
E.R. Squibb & Sons, L.L.C. $166.34 9 $0 (2024)
ABBVIE INC. $156.46 11 $0 (2024)
Agios Pharmaceuticals, Inc. $123.26 2 $0 (2024)
Rigel Pharmaceuticals, Inc. $107.78 4 $0 (2024)
PFIZER INC. $102.87 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,572 82 Novartis Pharmaceuticals Corporation ($286.24)
2023 $1,294 75 Daiichi Sankyo Inc. ($315.16)
2022 $518.26 26 Daiichi Sankyo Inc. ($132.01)
2021 $44.33 3 Eisai Inc. ($15.27)

All Payment Transactions

186 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
12/21/2024 ABBVIE INC. EPKINLY (Drug) Food and Beverage In-kind items and services $10.46 General
Category: ONCOLOGY
12/19/2024 Janssen Biotech, Inc. RYBREVANT (Drug) Food and Beverage In-kind items and services $18.63 General
Category: Oncology
12/19/2024 Janssen Biotech, Inc. DARZALEX (Biological), TECVAYLI, TALVEY Food and Beverage In-kind items and services $18.02 General
Category: Oncology
12/16/2024 REVANCE THERAPEUTICS, INC. DAXXIFY (Drug) Food and Beverage In-kind items and services $83.18 General
Category: AESTHETICS AND THERAPEUTICS
12/11/2024 Novartis Pharmaceuticals Corporation PLUVICTO (Drug) Food and Beverage In-kind items and services $33.25 General
Category: Oncology
12/11/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $20.17 General
Category: Oncology
12/10/2024 ABBVIE INC. EPKINLY (Drug) Food and Beverage In-kind items and services $8.84 General
Category: ONCOLOGY
12/05/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $22.19 General
Category: ONCOLOGY
12/02/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $20.14 General
Category: Immunology
11/21/2024 ABBVIE INC. IMBRUVICA (Drug), EPKINLY Food and Beverage In-kind items and services $15.46 General
Category: ONCOLOGY
11/19/2024 Rigel Pharmaceuticals, Inc. Rezlidhia (Drug), Tavalisse Food and Beverage Cash or cash equivalent $17.77 General
Category: Acute Myeloid Leukemia
11/13/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $15.72 General
Category: ONCOLOGY
11/11/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $14.51 General
Category: Oncology
11/07/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $19.86 General
Category: ONCOLOGY
11/06/2024 Janssen Biotech, Inc. DARZALEX (Biological), TECVAYLI, TALVEY Food and Beverage In-kind items and services $17.73 General
Category: Oncology
10/31/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $16.02 General
Category: Oncology
10/30/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $19.39 General
Category: Oncology
10/29/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $17.14 General
Category: Rare Disease
10/24/2024 GlaxoSmithKline, LLC. JEMPERLI (Biological), ZEJULA Food and Beverage In-kind items and services $21.73 General
Category: ONCOLOGY
10/23/2024 ABBVIE INC. EPKINLY (Drug) Food and Beverage In-kind items and services $30.33 General
Category: ONCOLOGY
10/22/2024 PFIZER INC. OXBRYTA (Drug) Food and Beverage In-kind items and services $14.88 General
Category: HEMATOLOGY
10/21/2024 Agios Pharmaceuticals, Inc. PYRUKYND (Drug) Food and Beverage In-kind items and services $16.39 General
Category: Genetically Defined Disease
10/17/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $21.13 General
Category: RADIOPHARMACEUTICAL
10/16/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), WELIREG Food and Beverage In-kind items and services $15.09 General
Category: ONCOLOGY
10/09/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $24.01 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 22 94 $18,410 $5,558
2022 2 53 171 $36,945 $11,624
2021 4 75 228 $44,992 $15,835
2020 3 145 246 $37,755 $9,861
Total Patients
295
Total Services
739
Medicare Billing
$42,878
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 22 94 $18,410 $5,558 30.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 26 79 $15,405 $4,798 31.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 12 45 $12,375 $4,210 34.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 15 47 $9,165 $2,616 28.5%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 27 115 $22,425 $7,460 33.3%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 11 41 $11,275 $4,136 36.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 13 34 $6,630 $2,302 34.7%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2021 11 17 $2,142 $1,157 54.0%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 13 21 $2,520 $780.47 31.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 59 117 $22,815 $5,950 26.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 62 93 $11,160 $2,797 25.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 12 24 $2,880 $835.26 29.0%
G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) Facility 2020 12 12 $900.00 $279.12 31.0%

About Robert Duncan, P.A

Robert Duncan, P.A is a Physician Assistant healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669492609.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Duncan, P.A has received a total of $3,429 in payments from pharmaceutical and medical device companies, with $1,572 received in 2024. These payments were reported across 186 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,429).

As a Medicare-enrolled provider, Duncan has provided services to 295 Medicare beneficiaries, totaling 739 services with total Medicare billing of $42,878. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location Shreveport, LA
  • Active Since 07/20/2006
  • Last Updated 06/19/2008
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1669492609

Products in Payments

  • INJECTAFER (Drug) $266.67
  • Enhertu (Drug) $225.91
  • KEYTRUDA (Biological) $208.87
  • Fabhalta (Drug) $170.43
  • IMBRUVICA (Drug) $168.47
  • EPKINLY (Drug) $160.21
  • DARZALEX (Biological) $157.64
  • OPDIVO (Biological) $150.75
  • PROMACTA (Drug) $124.86
  • PYRUKYND (Drug) $123.26
  • Rezlidhia (Drug) $107.78
  • OXBRYTA (Drug) $107.41
  • CALQUENCE (Drug) $100.18
  • Lenvima (Drug) $96.43
  • LIBTAYO (Biological) $92.03
  • DAXXIFY (Drug) $83.18
  • ULTOMIRIS (Biological) $79.99
  • KISQALI (Drug) $68.90
  • ENHERTU (Drug) $66.91
  • SCEMBLIX (Drug) $57.88

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Shreveport